drugset / Trial / NCT01819870
Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetic characteristics and safety of dilatrend SR capsule 32mg and Dilatrend tablet 25mg in healthy male subjects.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-05
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dilatrend SR capsule 32mg | Unknown | 25 mg | Oral |
| Subject | Dilatrend SR capsule 32mg | Unknown | 32 mg | Oral |